Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of basic and diluted net loss per share attributable to ordinary shareholders

Basic and diluted net loss per share attributable to ordinary shareholders was calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended March 31, 2026
	Loss Allocation		Weighted Average Shares Outstanding	Loss Per Share, Basic and Diluted
Ordinary Shares	$	(21,262)	30,397,886	$	(0.70)
Company Series A Preferred Shares (1)	(2,021)		2,890	$	(699.31)
Net loss	$	(23,283)


	Three Months Ended March 31, 2025
	Loss Allocation		Weighted Average Shares Outstanding	Loss Per Share, Basic and Diluted
Common Stock	$	(15,148)	771,851	$	(19.63)
Net loss	$	(15,148)

(1) The weighted-average number of shares of as-converted Series A Preferred Shares used in the loss allocation was 2,890,000 for the three months ended March 31, 2026.

Schedule of anti-dilutive net loss per share attributable to ordinary shareholders

The potential ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented because including them would have had an anti-dilutive effect were as follows:


	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Convertible preferred stock (as converted to common stock)	—	2,890,000
Outstanding unvested restricted stock units	607,121	438,386
Outstanding unvested restricted stock awards	74,701	246,753
Outstanding and issued common stock options	6,321,653	2,835,813
Total	7,003,475	6,410,952